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Abstract
Introduction: Hemodynamic management in intensive care patients guided by blood pressure and flow
measurements often do not sufficiently reveal common hemodynamic problems. Trans-esophageal echocardiography
(TEE) allows for direct measurement of cardiac volumes and function. A new miniaturized probe for TEE (mTEE)
potentially provides a rapid and simplified approach to monitor cardiac function. The aim of the study was to assess
the feasibility of hemodynamic monitoring using mTEE in critically ill patients after a brief operator training period.
Methods: In the context of the introduction of mTEE in a large ICU, 14 ICU staff specialists with no previous TEE
experience received six hours of training as mTEE operators. The feasibility of mTEE and the quality of the obtained
hemodynamic information were assessed. Three standard views were acquired in hemodynamically unstable
patients: 1) for assessment of left ventricular function (LV) fractional area change (FAC) was obtained from a trans-
gastric mid-esophageal short axis view, 2) right ventricular (RV) size was obtained from mid-esophageal four
chamber view, and 3) superior vena cava collapsibility for detection of hypovolemia was assessed from mid-
esophageal ascending aortic short axis view. Off-line blinded assessment by an expert cardiologist was considered
as a reference. Inter-rater agreement was assessed using Chi-square tests or correlation analysis as appropriate.
Results: In 55 patients, 148 mTEE examinations were performed. Acquisition of loops in sufficient quality was
possible in 110 examinations for trans-gastric mid-esophageal short axis, 118 examinations for mid-esophageal four
chamber and 125 examinations for mid-esophageal ascending aortic short axis view. Inter-rater agreement (Kappa)
between ICU mTEE operators and the reference was 0.62 for estimates of LV function, 0.65 for RV dilatation, 0.76
for hypovolemia and 0.77 for occurrence of pericardial effusion (all P < 0.0001). There was a significant correlation
between the FAC measured by ICU operators and the reference (r = 0.794, P (one-tailed) < 0.0001).
Conclusions: Echocardiographic examinations using mTEE after brief bed-side training were feasible and of
sufficient quality in a majority of examined ICU patients with good inter-rater reliability between mTEE operators
and an expert cardiologist. Further studies are required to assess the impact of hemodynamic monitoring by mTEE
on relevant patient outcomes.
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Background
Hemodynamic monitoring plays an important role in
the management of intensive care unit (ICU) patients.
Monitoring using a pulmonary artery catheter has been
questioned due to the invasive nature of the method
and the lack of clear evidence for improved outcomes
associated with its insertion and use to guide therapy
[1]. Several alternative monitoring technologies have
been introduced for the monitoring of cardiac output
and stroke volume or their surrogates, such as trans-
pulmonary thermodilution and various other less invasive
techniques. However, the value of these monitoring tools
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also remains controversial and randomized controlled
studies showing improvement of relevant patient out-
come parameters due to the use of these devices do not
exist [2]. Decreased accuracy under certain conditions,
complexity of use and interpretation, and the need for
specially trained staff are common to all available moni-
toring tools [3].
Echocardiography has been established as a tool to
evaluate the causes of hemodynamic instability in ICU
patients by the visualization of cardiac chambers, valves
and pericardium and cardiac functional abnormalities
[4,5]. Transthoracic echocardiography (TTE) can be used
as a first-line approach for a quick and focused examina-
tion to diagnose acute cor pulmonale, cardiac tamponade
or major left ventricular systolic dysfunction [6]. The
training necessary to reliably perform such an abbreviated
TTE use is substantial [7] and the method is not readily
available for every intensivist. Trans-esophageal echocar-
diography (TEE) can have a better diagnostic capability
and is more reproducible than TTE [8]. A minimum num-
ber of 31 TEE examinations has been reported to be
required for intensivists to achieve competence in TEE
driven hemodynamic evaluation of ventilated ICU patients
[9]. Additionally, repeatedly inserting the TEE probe as
required for serial evaluation of a patient’s hemodynamic
status is associated with a small but significant risk of
injury to oral and esophageal structures [6].
Recently, a new technology using miniaturized probes
for continual or repeated prolonged monitoring using
TEE (mTEE) has been introduced. This approach poten-
tially provides a robust, but more rapid and user-friendly
approach to monitoring hemodynamic status and cardiac
function than conventional TTE and TEE. In a recently
published study by Vieillard-Baron et al. the feasibility of
hemodynamic monitoring and safety of mTEE were
demonstrated in a group of 94 ventilated critically ill
patients [10]. In this study, mTEE examinations were per-
formed by four highly trained intensivist with extensive
expertise in critical care echocardiography. However, the
results of this study cannot be extended to prove the
ability of operators with no previous experience in TEE to
efficiently conduct hemodynamic assessment using mTEE.
The usefulness of a specific monitoring device in a clinical
setting is also determined by the ease of its use and the
amount of training required for the intensivist to obtain
reliable data.
The objective of the study at hand was to assess the abil-
ity of novice operators with no previous experience in TEE
to efficiently conduct hemodynamic assessments in an
ICU setting. We systematically evaluated the image quality
and inter-observer reliability during the introduction of
the mTEE monitoring system in the ICU of a tertiary care
center.
Methods
This study is based on data collected during the pro-
spective process quality audit in the context of the
introduction of mTEE for clinical use in the Department
for Intensive Care Medicine at the University Hospital of
Bern, Switzerland and adheres to the tenets of the Declara-
tion of Helsinki. The study protocol was submitted to the
Ethical Committee of the Canton of Bern; the need for
ethical approval was waived provided that purely observa-
tional data were collected in conjunction with the process
quality audit. Nevertheless, all patients admitted to the
Bern University Hospital are routinely informed of their
right to specify whether data related to their stay can
be used in observational studies; data of patients who
declined were not included in the study.
The ImaCor ClariTEE® probe is a miniaturized, 5.5 mm
monoplane TEE probe (ClariTEE, ImaCor, Uniondale,
NY, USA). The probe produces standard monoplane
(transverse, 0-degree) two-dimensional images; anteflexion
and retroflexion of the tip of the probe is possible. The
probe is approved to remain in situ for 72 h. It is con-
nected to a dedicated ultrasound system which allows
for recording of digital loops and performance of basic
two-dimensional measurements of areas and distances.
Data were collected between February 2012 and
August 2012 for the first 55 patients in whom the device
was used. Patient population included both medical and
surgical patients. Only patients on mechanical ventilation
with an orotracheal tube in place were examined. Venti-
lator settings routinely used in our department consist of
volume controlled immediately after intubation and pres-
sure support thereafter. Ventilator settings were not
changed for the purpose of mTEE assessments; the
department’s standard sedation protocol was used to
avoid patient-ventilator dyssynchrony. The exclusion cri-
teria for the use of mTEE in our institution are as follows:
unrepaired tracheoesophageal fistula, history of prior
esophageal surgery, esophageal obstruction or stricture,
esophageal varices or diverticulum, perforated hollow
viscus, gastric or esophageal bleeding, vascular ring,
aortic arch anomaly with or without airway compromise,
oropharyngeal pathology, severe coagulopathy, and cervi-
cal spine injury or anomaly. The decision to use mTEE
for hemodynamic monitoring was made by the treating
staff specialist on clinical grounds.
Fourteen ICU staff specialists - none of whom had
received any training in TEE before the study - received a
total of six hours training in the use of mTEE by an
experienced operator. Training included a 60-minute
introduction of the method and demonstration of device
use in the context of a presentation, followed by five hours
of one-to-one bedside training in small groups of two to
three trainees during the same day. Training included all
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necessary skills to use the mTEE device, and to acquire
and interpret images according to predefined parameters.
The mTEE examinations performed during the training
period were not included in the analysis for the study at
hand. At the time of the study, TEE examinations in our
department were exclusively performed by an on-call
cardiologist and not by intensive care staff; whereas 4 of
the 14 operators assessed in the study had experience in
TTE examination.
The decision to use mTEE for hemodynamic monitor-
ing was at the discretion of the staff specialist responsible
for the treatment of a patient and was not mandated by
the study protocol. After positioning of the mTEE probe,
three standard TEE views [11] were acquired, recorded
and evaluated at the time of ICU admission or at the
time of occurrence of hemodynamic instability by the
ICU specialist in charge of the patients care: transgastric
mid-esophageal short axis view, mid-esophageal four
chamber view, and mid-esophageal ascending aortic
short axis view. Left ventricular (LV) area at end-systole
(LVESA) and at end-diastole (LVEDA) was measured
from the transgastric mid-esophageal short axis view, the
fractional area change (FAC) was calculated as LVEDA-
LVESA/LVEDA and used to grade LV ejection fraction
as normal (FAC >50%), moderately decreased (FAC 40 to
50%) or severely decreased (FAC <40%). Similarly, the
ratio of right to left ventricular (RV) area was determined
by measurements at end-diastole in the ME 4 chamber
view. A ratio >0.6 was used as indicator of RV dysfunc-
tion [11]. The collapsibility of the superior vena cava was
rated by calculating the collapsibility index, that is, the
inspiratory decrease in superior vena cava diameter. The
index was determined as (maximal diameter on expira-
tion-minimal diameter on inspiration)/maximal diameter
on expiration, expressed as a percentage. We used a
threshold of >35% to distinguish between the presence
and absence of hypovolemia [12].
After image acquisition the operator completed a
questionnaire on the patient’s hemodynamic condition
based on the mTEE information. This included rating of
systolic LV function (normal, moderately decreased or
severely decreased), rating of RV size as dilated or not
dilated, and presence or absence of hypovolemia and
pericardial effusion. In addition, operators were asked to
evaluate the difficulty to acquire the mTEE views (rated
as easy, moderately difficult, difficult, not possible) and
the utility of the information obtained by mTEE and to
record if any changes in hemodynamic management
(administration of additional fluids, dose adjustments of
vasopressors/inotropes, drainage of pericardial effusion)
were made on the basis of the acquired mTEE data. An
independent observer (study nurse) recorded data during
the mTEE examination regarding the successful use of
the system and time from start of the system set-up at
the bedside to completion of the questionnaire regarding
the patient’s hemodynamic condition.
All recorded mTEE views and measurements were
assessed off-line by an expert cardiologist blinded to
the patients and the mTEE operator’s identity and to
the results of the operator’s examination. The mTEE
views were assessed for adequate quality to measure
FAC (transgastric mid-esophageal short axis view),
RV/LV ratio (mid-esophageal four chamber view M)
and superior vena cava collapsibility index (mid-esophageal
ascending aortic short axis view). The cardiologist mea-
sured LV areas at end-systole and at end-diastole and
calculated FAC for every patient and answered the same
predefined questions about the hemodynamic condition
based on the recorded mTEE views (systolic LV function
normal - moderately decreased - severely decreased, RV
dilatation present or absent, hypovolemia present or
absent, significant pericardial effusion present or absent).
Statistical analysis
Continuous variables are presented as mean (standard
deviation) or median (interquartile range). Normality
testing was performed using the Kolmogorov-Smirnov
test. For comparison of mTEE measurements of ICU
staff specialists and the cardiologist inter-rater reliability
for categorical variables was assessed using a Chi-square
test. Inter-rater agreement (kappa statistics) was deter-
mined. Pearson’s r (1-tailed) was used to determine inter-
rater reliability for continuous variables (FAC). A P-value
of < 0.05 was considered statistically significant. Standard
statistic software was used (IBM SPSS Statistics 19,
Somers, NY 10589, USA).
Results
Patients
A total of 148 examinations were performed in 55
patients (mean age 63.7 ± 16.7 years, 59% male) during
the study period, according for 2.7 ± 1.9 examinations
per patient. Indication for mTEE assessment was circu-
latory failure in 45 patients (cardiogenic shock in 17
patients, septic shock in 17 patients, cardiac dysfunction
post cardiac surgery in 8 patients, post resuscitation syn-
drome in 3 patients) and respiratory failure in 5 patients
(3 patients pneumonia, 2 patients thoracic trauma)
whereas 5 patients had other, miscellaneous indications.
The mean duration of mTEE monitoring period in
which the probe was left in place was 28 ± 16 hours.
Examination feasibility and quality
All ICU staff specialists were able to use the system
correctly and to store images and video loops after
initial training. Median time from start-up of the device
until completion of examination and recording of results
was 23 minutes (IQR 15 to 28) if the mTEE probe was
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already in place and 25 minutes (IQR 20 to 33) if
the mTEE probe had to be inserted. Insertion and/or
acquisition of mTEE images required removal of the naso-
gastric tube in nine patients (16%) only for the initial
placement and in six patients (11%), repeatedly accounting
for the necessity of removal in 24 (16%) of all 148 exami-
nations. Acquisition of the loops was considered easy
in approximately half of the examinations and not possible
in 9 to 10% of the examinations (Figure 1).
The quality of mTEE views was considered sufficient
to assess the predefined hemodynamic parameters by
the expert cardiologist in 110 examinations for trans-
gastric mid-esophageal short axis, in 118 examinations
for mid-esophageal four chamber and in 125 examina-
tions for mid-esophageal ascending aortic short axis
view (Figure 2). No complications due to mTEE use
occurred during the study.
Mean FAC was 47 ± 17%, and LVEF was described as
normal in 45%, moderately decreased in 19% and severely
decreased in 36% of examinations; RV-dilatation was pre-
sent in 48% of the examinations, hypovolemia was
detected in 5% and pericardial effusion was present in
23% of examinations. Inter-rater agreement between ICU
mTEE operator and the expert cardiologist for estimates
of LV function (Kappa 0.62, P < 0.0001), RV dilatation
(Kappa 0.65, P < 0.0001) hypovolemia (Kappa 0.76,
P < 0.0001) and occurrence of pericardial effusion
(Kappa 0.77, P < 0.0001) was substantial. There was
a significant correlation between the FAC measured
by ICU operators and the cardiologist (r = 0.794,
P (one-tailed) < 0.0001) (Figure 3).
Of the total of 148 mTEE assessments, the information
acquired was rated as useful for the ongoing hemodynamic
management of the respective patient in 113 (76%) exami-
nations. A total of 56 changes in hemodynamic manage-
ment after mTEE assessment of the respective patient
were reported in 50 (34%) examinations. Management
changes included administration of fluids in 19 instances
(13%), start or increase of inotropes/vasopressors in
23 (16%), stop or decrease of inotropes/vasopressors in
10 (7%) and drainage of pericardial effusion following
4 examinations (3%).
Discussion
Our study shows that the use of mTEE by operators not
previously trained in TEE can be introduced successfully
in an ICU setting of a tertiary hospital. Echocardio-
graphic examinations by operators using mTEE after
six-hour bedside training were technically feasible and
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Figure 1 Difficulty of acquiring mTEE views. Difficulty of acquisition and image quality of three different transverse views obtained using the
mTEE probe in 148 examinations of 55 patients with hemodynamic compromise. Difficulty of acquiring the views was rated by the ICU mTEE
operator. ICU, intensive care unit; ME 4 chamber, mid-esophageal four chamber view; ME asc aortic SAX, mid-esophageal ascending aortic short
axis view; mTEE, miniaturized trans-esophageal echocardiography; TG mid SAX, trans-gastric mid-esophageal short axis view.
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patients. Inter-rater reliability between assessment by
ICU mTEE operators and a trained cardiologist was sub-
stantial. Hemodynamic assessment using mTEE might,
therefore, provide a valuable alternative to standard
TTE or TEE-examination or conventional hemodynamic
monitoring for a rapid, semi-quantitative assessment of
LV and RV function and volume status.
We evaluated a monoplane, oral mTEE probe for
hemodynamic monitoring in a population of critically ill
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Figure 2 Quality of mTEE views. Percentage of all attempted views that were acquired stratified by the three standard mTEE views (TG mid
SAX, ME 4 Chamber, ME asc aortic SAX) and proportion of all attempted loops and acquired loops with sufficient quality as assessed by a
trained cardiologist. ME 4 chamber, midesophageal four chamber view; ME asc aortic SAX, mid-esophageal ascending aortic short axis view;
mTEE, miniaturized trans-esophageal echocardiography; TG mid SAX, trans-gastric mid-esophageal short axis view
Figure 3 Accuracy of measurements of left ventricular systolic function. Assessment of the accuracy of measurements of left ventricular
systolic function using the mTEE probe in 148 examinations of 55 patients with hemodynamic compromise. Measurements of left ventricular function
fractional area change (FAC) by ICU operators were repeated by a trained cardiologist blinded to the patients and the mTEE operator’s identity and
to the results of the operator’s examination. Correlation analysis revealed substantial inter-rater reliability of LV FAC measurements (r = 0.794,
P (one-tailed) < 0.0001). ICU, intensive care unit; LV FAC, fractional area change of left ventricle; mTEE, miniaturized trans-esophageal echocardiography
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bed-side training our staff specialists were able to
acquire and correctly interpret relevant information on
key hemodynamic parameters. The acquired information
was rated as useful for hemodynamic management in a
majority of patients and led to therapeutic changes in a
relevant proportion. No device specific complications
occurred. The time needed for system start-up and to
acquire the three mTEE views and process the images
was substantial, but was comparable with the insertion
of central lines for hemodynamic monitoring. Addition-
ally, the duration is partially explained by the fact that
in the context of the study we required the operators to
assess and record all information in a protocolized fash-
ion for every evaluation. In clinical practice, this is not
necessary and real-time monitoring of hemodynamic
parameters can be performed while the mTEE probe is
left in situ for up to 72 hours. Our results are compar-
able with a recently published study by Vieillard-Baron
et al. who evaluated the hemodynamic monitoring cap-
ability and safety of mTEE in a group of 94 ventilated
critically ill patients [10]. The authors reported that a
full hemodynamic evaluation (acquisition of all three
mTEE views in optimal or acceptable quality) was possi-
ble in 85% of examinations. In their study 50% of hemo-
dynamic assessments had a direct therapeutic impact.
Fluid loading was performed in 41% patients, and ino-
tropic or vasopressor support was initiated or increased
in 33% and tapered off in 8% of patients.
Minor self-limited gastric bleeding mechanical ulcera-
tion of the superior lip was observed in two patients.
However, mTEE examinations were performed by four
highly trained intensivists with extensive expertise in cri-
tically care echocardiography. The authors state that
their results cannot be extended to prove the ability of
novice operators with no previous experience in TEE to
efficiently conduct hemodynamic assessment using the
tested device. Our results now also demonstrate that
novice operators can obtain valid and clinically relevant
hemodynamic data with mTEE although the success rate
of obtaining images in sufficient quality was lower than
the reported success rate of experienced TEE operators
in the study of Vieillard-Baron et al. [10].
In an ICU setting, the ideal monitoring technique
allows for fast and simple but accurate continuous mea-
surement of key hemodynamic parameters, is of low
invasiveness and does not require extensive training for
its use [3]. Such a system does not currently exist but
we must try and choose devices that have a maximum
of these attributes and select the technique not only
most appropriate for each patient, but also for each
user. No hemodynamic monitoring improves patient
outcome by itself. The quality of the obtained information,
the correct interpretation of the data and the changes in
management made as a result are of integral importance
and have to be considered when assessing the clinical
usefulness of novel monitoring modality.
Bedside echocardiography is considered a promising
tool for the management of critically ill patients [13],
and has been demonstrated to be useful in establishing
the diagnosis and provides hemodynamic monitoring
[14-16]. However, conventional TTE and TEE are not
always readily available in an ICU setting. Additionally,
TTE image quality is often impaired by factors such as
sternotomies, chest drains, dressings or positive pressure
ventilation leading to reported failure rates between 10
and 30% in different groups of ICU patients [17,18].
The approach of evaluating hemodynamic status by a
simplified, time-sparing TEE examination for manage-
ment of circulatory failure in septic shock has been
successfully studied by others [19]. Nevertheless, a con-
ventional TEE probe cannot be left in the patient for
more than a few hours and repeated examinations are
again time-consuming and may be associated with the
increased risk of complications associated with the rein-
sertion [20]. The use of a transnasal, miniaturized TEE-
probe has been shown to be feasible even in mildly
sedated, intubated patients who were not fully coopera-
tive and to provide information on cardiac function to
the same extent as a conventional trans-oral monoplane
TEE examination [21]. The transnasal probe seems to
be better tolerated, but led to nasal bleeding in 31% of
the study population. The main difference between the
mTEE technology and a conventional TEE system is the
possibility of leaving the probe in place for up to 72 h
for repeated assessments and monitoring of the patient’s
condition. The use of the mTEE technology is limited by
the lower resolution of the transducer and the lack of
M-mode and pulsed wave and continuous wave Doppler.
On the other hand, the disposable mTEE probe is detach-
able from the echo machine to allow the monitoring of
several patients in a semi-continuous fashion with one
device. How this new technology compares to other
ultrasound-based or non-ultrasound-based monitoring
modalities in terms of efficiency and efficacy remains to
be studied.
Our study has several limitations. First, we did not
compare the ability of a novice ICU operator with a
TEE-trained cardiologist to obtain the images with the
mTEE probe. It is conceivable that the high success rate
could have been further improved by a trained expert. A
study design allowing such comparison during hemody-
namic instability could be hampered by relevant ongoing
changes during the process of hemodynamic stabiliza-
tion with fluids and vasopressors. We, therefore, chose
to compare the interpretation of data off-line. Secondly,
the study design allowed the use of any other, conven-
tional hemodynamic monitoring modality at the discre-
tion of the ICU specialist in charge of the patient.
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We cannot exclude that some of the reported decisions to
change hemodynamic management also utilized additional
available parameters rather than solely those acquired
by mTEE - a practice we strongly advocate in the clinical
routine of any hemodynamic monitoring. In our study,
although hypovolemia was detected only in 5% of exami-
nations, fluids were given nearly three times as often. We
did not record the precise indication for the fluid adminis-
tration, but assume that mTEE was also used to exclude
dilated RV or LV when the aim was to enhance cardiac
output or peripheral tissue perfusions with fluids. The
impact on patient management was not the main outcome
parameter of this feasibility study and we did not compare
the effectiveness of mTEE monitoring with other monitor-
ing technologies. Finally, it has to be emphasized that we
report on the first mTEE examinations of each novice
operator. The method of use in the context of the intro-
duction of this new technology potentially does not reflect
the future modalities of mTEE. Increasing experience
might influence the decision processes for its use, such as
patient selection and examination intervals, as well as
technical properties such as time requirements for and
quality of mTEE studies.
Conclusions
In summary, our study shows that hemodynamic moni-
toring using the mTEE-system is feasible and provides
additional, valid data for the management of critically ill
patients after a brief training period of the operator.
Further studies are required to assess the impact of
hemodynamic monitoring by mTEE on relevant patient
outcomes.
Key messages
• Hemodynamic monitoring of ICU patients using
the mTEE-system by operators not formally trained
in TEE is feasible with minimal training.
• Hemodynamic monitoring of ICU patients using
the mTEE-system provides additional, valid data for
the management of critically ill patients.
• Further studies are required to assess the impact of
hemodynamic monitoring by mTEE on relevant
patient outcomes.
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